T he most common cause of lacrimal drainage system obstruction is nasolacrimal duct obstruction (NLDO), which leads to complaints such as epiphora and dacryocystitis. The obstruction can be congenital or acquired. Acquired NLDO is mostly seen in patients aged >40 years and its incidence rapidly increases in those aged >60 years [1] . Known risk factors are advanced age, white race, female sex (4-5-fold), and low socioeconomic status [2] [3] [4] . Primary acquired NLDO is mostly idiopathic, whereas secondary acquired NLDO may be due to trauma, infection, inflammation, neoplasm, or mechanical factors [1] .
The goal in the treatment of NLDO is to maintain the drainage of tears. Medical treatment is performed in acute cases. Definitive treatment in cases wherein medical treatment is inadequate and in cases of chronic dacryocystitis is surgery [5] . The primary option in surgery is dacryocystorhinostomy (DSR), namely creating a new permanent pathway between the lacrimal sac and the nasal mucosa. The first known external DSR operation was described by Toti in 1904 [6] . Although treatment via external surgical approach is still the gold standard with the highest success rate, the latest development in DSR is the endocanalicular Laser-assisted DSR application was introduced by Massaro et al. in 1990 with cadaver studies using a blue-green argon laser. Eventually, Reifler used potassium titanyl phosphate in 1993, then holmium YAG, CO 2 , Nd:YAG, and erbium lasers have been also used [7] [8] [9] . Subsequent studies have shown delayed postoperative wound healing and prolonged inflammation in laser-treated tissues in CO 2 laser and Nd:YAG laser applications [10] . Diode laser (980 nm) is the most preferred method in terms of both low tissue damage and adequacy of the osteotomy to be created. The first endoscopic DSR surgery with diode laser was implemented by Eloy et al. in 2000 and maintained its up-to-dateness afterward [11] .
Some investigators prefer silicone tube intubation in all cases of NLDO surgery [12] , whereas others prefer silicone tube intubation only for definite indications (canalicular injury, lacrimal sac inflammation, secondary surgery, small, contralateral sacs, etc.) [13] .
The aim of this retrospective study was to compare the surgical outcomes of the transcanal diode laser DSR (TDL-DSR) surgery with and without bicanalicular silicone tube intubation in the treatment of 61 patients with primary uncomplicated NLDO.
Materials and Methods
In this study, 61 eyes of 61 patients with primary NLDO who underwent TDL-DSR at our clinic between 2015 and 2017 were included. The study was carried out in accordance with the principles of the Helsinki Declaration. Informed consent form was obtained from all patients. Patients were divided into two groups and retrospectively examined. Group 1 consisted of 30 patients who underwent TDL-DSR with bicanalicular silicone tube intubation and Group 2 consisted of 31 patients who underwent TDL-DSR without bicanalicular silicone tube intubation. After completion of the ocular examination, NLDO was preoperatively confirmed with lacrimal irrigation, and presence of lacrimal sac was observed with direct dacryocystography with lipiodol injection.
Inclusion criteria of the study were as follows: (i) no history of nasolacrimal duct surgery; (ii) absence of canalicular obstruction; (iii) no evidence of traumatic injury to the eye or nasal region; (iv) no accompanying nasal pathology such as septum deviation, concha bullosa, nasal polyposis, and atrophic rhinitis; (v) absence of active infection of dacryocystitis; and (vi) absence of dry eye and ptosis of the lower lid.
All surgeries were performed under local anesthesia. Intramuscular benzodiazepine was administered to the patient. Prior to surgery, topical anesthetic drops (0.4% oxybutuproxine hydrochloride) were instilled into the conjunctiva and cornea. Then, intranasal and lateral nasal anesthesia was induced with a mixture of epinephrine hydrochloride and lidocaine solution.
Local anesthesia was induced in the region of the "infraorbital nerve" and "medial canthus" with the injection of a mixture of epinephrine hydrochloride and lidocaine solution (Jetokain® injection, ADEKA,Turkey). After dilation with punctum dilators, the flexible fiber DSR laser probe was advanced through the canal to the wall of the lacrimal sac. During this insertion, the probe coming into contact with a hard surface indicated that we were inside the lacrimal bone. Simultaneously, the endoscope and aspiration probe inserted through the nasal cavity allowed the visualization of the red light reflex at the end of the fiber on the nasal wall opposite the middle conical surface. In this way, the target tissue to be exposed to laser was precisely determined.
The parameters of the diode laser (INTERmedic™ diode S30 OFT 980 nm) were set as 500 ms pulse mode and 10 W to avoid unnecessary heating of the tissue. After reaching the nasal cavity, the osteotomy was extended to 1×1 cm, down, up, and to both sides. An aspirator was used to protect the middle concha and septum and aspirate the bleeding. The laser application was adjusted to 35-55 shots at 10 W. At the end of the operation, the laser probe was removed and the opening was checked by lacrimal duct lavage with saline.
In Group 1, bicanalicular silicone tube intubation was additionally performed. Silicone extensions of the tube were spliced and then released in the nasal cavity. Furacin (nitrofurazone 0.2%) impregnated pad was placed in the nasal cavity for hemostatic control. On the first postoperative day, the pad was removed. After surgery, antibiotics and steroid eye drops, nasal steroid sprays, and nasal saline solutions were recommended to be used four times daily for 2 weeks. In addition, oral antibiotics were recommended for 1 week.
Patients were controlled postoperatively at 1 day, 1 week, 1 month, 3 month, and then at intervals of 3 months. Care was taken to wait 6 months to remove the silicone tubes. In 4 patients, the tube was removed between 3 and 6 months on the request of the patient. During control visits, the patency of the lacrimal drainage system was checked. The absence of symptomatic epiphora and smooth passage of the nasolacrimal lavage fluid were defined as success. The mean follow-up period was 13±0.6 months for Group 1 and 13±0.4 months for Group 2.
Statistical Analysis
Statistical analyses were performed using SPSS 14.0 (Statistical Package for Social Sciences, SPSS Inc., Chicago, IL). Normal distribution of the variables in consideration was first assessed using the Shapiro-Wilk test. Data were presented as mean±standard deviation for continuous variables and categorical data were expressed as the number of cases. Independent sample test was used to compare the means of Group 1 to Group 2. Differences between the groups were analyzed using chi-square test.
Results
The study population of 61 patients was divided into Group 1 (16 females and 14 males; mean age, 55.36±33.21 years) and Group 2 (16 females and 15 males; mean age, 52.18±25.21 years). There was no statistically significant difference between the groups in terms of age and sex distribution (p>0.05). Surgical success rates achieved in patients as evaluated at 1 year postoperatively were 80.0% (24/30) for Group 1 and 64.5% (20/31) for Group 2. A statistically significant difference was observed between the groups in terms of surgical success rates (p=0.03).
The mean operative times for Groups 1 and 2 were 45.8±10.2 and 25.2±5.3 minutes, respectively. Surgery lasted longer in Group 1 due to the additionally applied tube intubation with a statistically significant intergroup difference (p=0.02). The mean total laser energy used in Groups 1 and 2 were 627±68.3 and 638±71.4 J, respectively. There was no statistically significant difference between the groups in terms of the total mean laser energy used (p>0.05). Characteristics of Groups 1 and 2 are shown in Table 1 .
When the success rates calculated at 1, 3, and 6 months and at 1 year postoperatively were evaluated, higher operative success rates were achieved at 1, 3, and 6 months in Group 1, without any statistically significant difference between the groups. The operative success rate in Group 2 decreased in the first postoperative year, and the success rates between the two groups for the first year were statistically significant (p=0.03). The success rates at postoperative controls are shown in Table 2 .
Granuloma was detected during endoscopic examinations in 2 patients in Group 1. These granulomas were removed by the otolaryngologist using endoscopic procedures. Because of the mucosal scarring around the osteotomized area, outcomes in 4 cases were evaluated as failure. There were no other complications such as erosion of the punctum, skin fistula, and removal of the tubes. In Group 2, endoscopic examinations revealed secondary ostium scar formation in 8 patients and epiphora persisted in 3 patients. Reoperation was performed between 3 and 6 months in 2 patients. One patient in Group 2 developed dacryocystitis at postoperative 1 month.
Discussion
During the first 6 months after TDL-DSR, success rates were similar between the two groups. After 6 months, the silicone tube was not applied, the osteotomy area was closed, and the success rate gradually decreased. In the first year, the success rate was higher in the group treated with silicone tube intubation. Because silicone tube prevented further closure of the opening.
TDL-DSR is a minimally invasive surgical procedure and has the great advantage of accessing the operation area through anatomic routes. It minimizes trauma to the surrounding tissue, protects the medial canthal ligament, prevents unnecessary surgical skin scarring, and allows ablation, dissection, and removal of the tissue. In addition, TDL-DSR causes minimal pain and minimal nasal bleeding. It is also possible to intervene simultaneously with nasal pathologies. Compared with the conventional dacryocystorhinostomy, it is easier and quicker to perform. However, TDL-DSR has many disadvantages: it requires training in the use of laser and endoscopy, it has a lower success rate than the conventional external DSR method, and materials used are more expensive [14] .
Silicone tube intubation during DSR is used to prevent occlusion of the lacrimal passage and to provide epithelization. Silicone is an inert substance, does not harm the conjunctiva, and can be well tolerated in the canaliculi. As noted above, silicone tube intubation is recommended for patients with coexisting canalicular diseases, narrowed or injured lacrimal sacs, and persistent congenital NLDO. Aytıntap et al. assessed the relationship between failure and age in TDL-DSR cases where they applied silicone tubing and found a relationship between failure and age. While the rate of failure was higher in younger patients, the rate of success increased with age [15] .
There are few studies in the literature regarding the use and non-use of silicone tube intubation in DSR. Although some studies have reported that silicone tube use is not a statistically significant advantage in DSR [16, 17] , other studies recommend tube intubation in DSR [18] .
Feng et al. [17] investigated 9 studies involving 514 cases in their meta-analysis and concluded that additional silicone tube intubation in dacryocystorhinostomy did not provide any additional benefit.
One of the most important factors for failure is narrow (<1 cm) osteotomy opening. In such cases, the risk of recurrence increases. In our study, osteotomy opening was >1 × 1 cm in all patients. However, it has been reported that specific wound healing and tissue response affect the patency of the passage independently of the osteotomy opening size [14] . The success rate in this study was 80.0% (24/30) in the TDL-DSR group and 64.5% (20/31) in the other DSR group without application of silicone tube, with a statistically significant difference between the groups (p≤0.05).
Success rates have been reported to range between 80% and 99% in external DSR cases and between 58% and 97% in endoscopic procedures [19, 20] . Mitomycin C administration to the osteotomy region is among the measures taken to prevent restenosis in the constructed osteotomy opening. Kar et al. [21] reported higher success rates for TDL-DSR procedures in which they applied mitomycin C to the osteotomy site. Antifibrotic agent was not used in our study.
There were 17 failures in our study: 6 failures in Group 1 and 11 failures in Group 2. In 2 failures in Group 1, granulomatous tissue formation occurred. In Group 2, dacryocystitis was observed in 1 patient. In addition, scars on the ostium were observed in 4 patients in Group 1 and in 11 patients in Group 2 during endoscopic examinations.
Rebeiz et al. [22] recommended 4-6 weeks for the duration of silicone tube intubation. To prevent granuloma formation, Kong et al. [23] suggested that the tubes should not be removed before 8 weeks. Häusler and Caversaccio reported that tubes are well tolerated by patients and that the nasolacrimal duct remains open for months or even years. In their study, the tubes remained in place for an average of 9 months [24] . In the current study, silicone tubes were removed after at least 6 months after surgery, except in 4 patients. The bicanalicular tubes in the lacrimal ducts were well tolerated by all patients without any significant problems. In the study, during silicon tube placement, care was taken not to traumatize the tissues, but to tie the ends of the silicone tube with an ideal tension.
In this study, we concluded that the success rates of the two TDL-DSR groups with and without silicone tube intubation were different. According to the results of this study, bicanalicular silicone tube intubation should be performed with TDL-DSR in patients with primary NLDO.
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